Genesem Inc.

KOSDAQ:A217190 Stock Report

Market Cap: ₩75.9b

Genesem Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Steve Shin

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenureno data

Recent management updates

Recent updates

Even With A 25% Surge, Cautious Investors Are Not Rewarding Genesem Inc.'s (KOSDAQ:217190) Performance Completely

Sep 17
Even With A 25% Surge, Cautious Investors Are Not Rewarding Genesem Inc.'s (KOSDAQ:217190) Performance Completely

The Return Trends At Genesem (KOSDAQ:217190) Look Promising

May 19
The Return Trends At Genesem (KOSDAQ:217190) Look Promising

Is Genesem (KOSDAQ:217190) A Risky Investment?

Apr 09
Is Genesem (KOSDAQ:217190) A Risky Investment?

Genesem Inc. (KOSDAQ:217190) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected

Feb 19
Genesem Inc. (KOSDAQ:217190) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected

Returns At Genesem (KOSDAQ:217190) Are On The Way Up

Jan 08
Returns At Genesem (KOSDAQ:217190) Are On The Way Up

Investors Don't See Light At End Of Genesem Inc.'s (KOSDAQ:217190) Tunnel

Dec 05
Investors Don't See Light At End Of Genesem Inc.'s (KOSDAQ:217190) Tunnel

These 4 Measures Indicate That Genesem (KOSDAQ:217190) Is Using Debt Safely

Nov 08
These 4 Measures Indicate That Genesem (KOSDAQ:217190) Is Using Debt Safely

Genesem (KOSDAQ:217190) Might Have The Makings Of A Multi-Bagger

Aug 13
Genesem (KOSDAQ:217190) Might Have The Makings Of A Multi-Bagger

Is Genesem (KOSDAQ:217190) A Risky Investment?

Jul 16
Is Genesem (KOSDAQ:217190) A Risky Investment?

Genesem's (KOSDAQ:217190) Anemic Earnings Might Be Worse Than You Think

Mar 27
Genesem's (KOSDAQ:217190) Anemic Earnings Might Be Worse Than You Think

Is Genesem (KOSDAQ:217190) Headed For Trouble?

Mar 09
Is Genesem (KOSDAQ:217190) Headed For Trouble?

These 4 Measures Indicate That Genesem (KOSDAQ:217190) Is Using Debt Extensively

Jan 12
These 4 Measures Indicate That Genesem (KOSDAQ:217190) Is Using Debt Extensively

Are Genesem Inc.'s (KOSDAQ:217190) Mixed Financials Driving The Negative Sentiment?

Nov 19
Are Genesem Inc.'s (KOSDAQ:217190) Mixed Financials Driving The Negative Sentiment?

CEO

Steve Shin (62 yo)

less than a year
Tenure

Mr. Steve Shin is Co-CEO and Head of Sales, Marketing & Business Development at Genesem Inc. He served as an Executive Vice President of Worldwide Manufacturing at Amkor Technology, Inc. since March 2021 u...


Leadership Team

NamePositionTenureCompensationOwnership
David Han
Founder & Chairmanno datano datano data
Steve Shin
Co-CEO and Head of Salesless than a yearno datano data
Samuel Han
Co-CEO & Head of Businessless than a yearno datano data
Young-Min An
CFO & Head of Financeno datano datano data
Kevin Cho
CTO and Head of Advanced Research & Developmentless than a yearno datano data
Hee-Dong Lee
GM & Head of Production Managementno datano datano data
0.8yrs
Average Tenure

Experienced Management: A217190's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/03 05:34
End of Day Share Price 2025/11/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genesem Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jang-wook ParkDaishin Securities Co. Ltd.